HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 352800Generated: October 30, 2026
Sodium Hydroxide → 1-[(5-Chloroindol-2-yl)sulfonyl]-3-(ethyl)piperazine
https://huagongshe.com/reaction/352800
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Ammonium Chloride | HCID 25517 | — |
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | HCID 22710634 | HCID 22710634 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | 1-[(5-Chloroindol-2-yl)sulfonyl]-3-(ethyl)piperazine | HCID 22709848 | — |
Reaction Steps
A 1N aqueous solution (16 ml) of sodium hydroxide was added to a 1,4-dioxane solution (200 ml) of 1-[(5-chloro-1-phenylsulfonylindol-2-yl)sulfonyl]-3-(ethyl)piperazine (3.78 g) and the resulting mixture was stirred at 80° C. for 11.5 hours. A saturated aqueous solution of ammonium chloride was added to the reaction mixture. Distilled water and ethyl acetate were then added and the water layer was extracted three time. The organic layers were combined, dried over anhydrous magnesium sulfate and distilled under reduced pressure to remove the solvent. The residue was subjected to chromatography on a silica gel column (methanol:methylene chloride=1:100), followed by crystallization from tetrahydrofuran—diethyl ether, whereby the title compound (2.54 g) was obtained as needle crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06747023B1 |
|---|
| Source dataset | uspto-grants-2004_06 |
|---|
| ORD ID | ord-405cd9d5df7248f09349e6d88a6a9ea3 |
|---|
| Source note | uspto-grants-2004_06 |
|---|